Latest
#Health4Sale | Tribunal orders controversial ambulance companies to pay back over half-a-billion rand
The Special Tribunal has ordered four ambulance companies run by Thapelo Buthelezi to pay back a total of over half-a-billion rand. The matter relates to contracts awarded by the Free State government, which were first reported on in Spotlight’s #Health4Sale series of investigative articles in 2018.
#InsideTheBox with Dr Andy Gray | Are clinical trial participants in South Africa protected?
Clinical trial participants appear to be well protected in South Africa, particularly as the country’s guidelines recognise the risks of research with international collaborators. The sudden end of US-funded clinical trials, however, is exposing some limitations of ethics codes and guidelines, argues Dr Andy Gray.
US pulls funding for South African medical research
US funding for clinical research in South Africa is incrementally being cancelled. This is happening through at least two processes – the first is by banning certain kinds of foreign grants called sub-awards (which is affecting everyone globally). The second is by failing to issue routine renewals of grants for clinical studies in South Africa. Spotlight and GroundUp break down the current situation.
Gauteng state doctors gear up to fight health department over overtime payments
Trade unions, medical associations and universities are raising the alarm that Gauteng budget cuts at the cost of doctors’ take-home pay will have dire consequences for public sector health. Meanwhile, the National Minister of Health has convened a committee to review the future of overtime for state doctors. Ufrieda Ho reports.
Large numbers of TB survivors in SA struggling with lung damage, experts say
There are over three million people alive in South Africa who have been cured of TB. But even after being cured, many continue to suffer the long-term after-effects of the disease. To find out more about this under-recognised problem, Spotlight recently attended a global gathering of experts focused on life after TB.
Cape Town study brings hope to newborns left behind in HIV treatment advances
Research led by Professor Adrie Bekker is paving the way for an important HIV medicine to be made available to neonates in a way that is both safe and much more convenient than previous options. Biénne Huisman met with the passionate clinician-scientist at her office in Cape Town.
High hopes for major TB vaccine study recently launched in Paarl
The world desperately needs an effective TB vaccine to reduce the illness and death still being caused by the centuries’ old bacterium. Chris Bateman visited a study site in Paarl where a promising experimental TB vaccine is now being tested as part of a large multi-country clinical trial.
Massive $200 million TB research programme derailed by US funding cuts
Just over a month after US President Donald Trump implemented a 90-day freeze of all foreign assistance, the future looks very uncertain for tuberculosis research. Among others, a large TB research programme that was worth up to $200 million was axed last week. Elri Voigt reports.
How an SAMRC study found that HIV deaths in SA may be massively undercounted
It is widely acknowledged among health and demographic experts that relying solely on what is written on death certificates does not paint an accurate picture of what people in South Africa are actually dying of. Now, an SAMRC study has provided evidence that the undercounting of deaths due to HIV might be even greater than previously thought. Chris Bateman reports.
Inside government’s confused response to the US funding crisis
In late-January, the US suspended billions of dollars worth of international aid, including for HIV-related programmes in South Africa. The South African government could have responded by triggering an emergency funding mechanism but has failed to do so yet. In the meantime, activists, health researchers and even technical advisors to government are growing increasingly frustrated with the government’s lack of transparency on this issue.
Growing the beta variant – young scientist remembers the day they danced in the lab
During South Africa’s COVID-19 hard lockdown, rising star scientist Dr Sandile Cele spent his Christmas holidays in a laboratory. Soon the 35-year-old became the first to successfully grow the beta variant of SARS-CoV-2 in the lab. Biénne Huisman spoke to Cele about how he did this, the string of accolades he received since, and his leap from a modest upbringing to the global scientific stage.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Praesent bibendum nulla eget lobortis finibus. Praesent a euismod nulla, vel ullamcorper lacus. Aenean auctor, nulla eu ultricies mattis, urna nisl ullamcorper purus, eu suscipit leo libero et elit. Quisque iaculis nisl a risus elementum, ac aliquam sem maximus.

-
Episode 1: Sexual and reproductive health rights
Aug 23, 2018 • 23:42
In this first episode of the Spotlight podcast host Nomatter Ndebele speaks to Dr Daphney Conco of Wits about what SRHR is and why it matters. We also hear from Vuyokazi Gonyela of TAC about their SRHR work in provinces. Finally, Nomatter chats to Spotlight guest editor Thuthu Mbatha about…
-
Episode 2: Life Esidimeni revisited
Aug 28, 2018 • 1:00:42
In episode 2 we catch up with the processes around the Life Esidimeni tragedy. Christine Nxumalo discusses what further action the families are hoping for. Tendai Mafuma provides fascinating insights into the prospects for criminal liability. Mark Heywood gives his views on the politics surrounding the case and what that…
-
Episode 3: Sasha Stevenson on what NHI and HMI means for healthcare reform in South Africa
Oct 5, 2018 • 00:18:53
At a recent civil society meeting jointly hosted by SECTION27 and Spotlight, Sasha Stevenson, head of health at SECTION27, presented on the implications of NHI and HMI for access to healthcare in South Africa. We now make her informative and thought-provoking presentation available as a podcast. (We apologise for the…
-
Episode 4: Marijuana, health and the law in South Africa
Dec 7, 2018 • 18:41
Host Nomatter Ndebele chats to Dr Michael Herbst of the Cancer Association of South Africa about the landmark Constitutional Court judgement on the possession and use of marijuana and the judgement’s implications for the health of people in South Africa.
-
Episode 5: Dr Fareed Abdullah on South Africa’s AIDS response
Dec 14, 2018 • 22:26
Dr Fareed Abdullah of the SA MRC, previously CEO of SANAC, recently addressed the TAC’s 20-year celebrations. Listen what he had to say about the history of South Africa’s AIDS response and where we are now.
-
Episode 6: Justice Edwin Cameron addresses the TAC 20-year celebrations
Dec 14, 2018 • 13:14
Justice Edwin Cameron of South Africa’s Constitutional Court recently addressed attendees at the TAC’s 20-year celebrations. We bring you a recording of what he had to say to TAC members, supporters and allies.
-
Episode 7: Lotti Rutter on PEPFAR funding and why we need a People’s COP
Jul 25, 2019 • 24:10
Nomatter Ndebele chats to Lotti Rutter of HealthGAP about what the People’s COP is and why it matters.
-
Episode 8: How South Africa is performing against key NSP indicators
Jul 25, 2019 • 19:30
Host Nomatter Ndebele chats to Spotlight editor Marcus Low about South Africa’s progress against key NSP indicators.
-
Episode 9: Rensburg on healthcare reform in South Africa
Jul 25, 2019 • 27:36
Host Nomatter Ndebele chats to RHAP director Russell Rensburg about the major reforms underway in the South African healthcare system.
-
Episode 10: Siphiwe Mhlangana on the Treatment Action Campaign’s treatment literacy work
Jul 25, 2019 • 21:15
Host Nomatter Ndebele chats to Siphiwe Mhlangana of the TAC about his treatment literacy work and why treatment literacy still matters.

Spotlight subscribes to the Code of Ethics and Conduct for South African Print and Online Media that prescribes news that is truthful, accurate, fair and balanced. If we don’t live up to the Code, within 20 days of the date of publication of the material, please contact the Public Advocate at 011 484 3612, fax: 011 484 3619. You can also contact the Press Council’s Case Officer on khanyim@ombudsman.org.za or lodge a complaint on their website: www.presscouncil.org.za